cfDNA’s Big Moment Has Arrived

Experts explore the promise, pitfalls, and future of cfDNA testing in modern laboratory medicine

Category	Detail
Condition	Cell-free DNA Testing
Key Mechanisms	Minimally invasive molecular information acquisition, longitudinal disease monitoring.
Target Population	Patients requiring prenatal testing, oncology patients, transplant recipients.
Care Setting	Clinical laboratories and pathology departments.

cfDNA testing is gaining traction across multiple areas of pathology.
It offers a complementary tool to traditional tissue biopsy for disease monitoring.
Established applications include prenatal testing, oncology, and solid organ transplantation.
Technical challenges include low cfDNA concentrations and the need for sensitive assay technologies.
Integration into existing workflows requires strong preanalytic controls and robust bioinformatics.

cfDNA should be integrated with clinical context and other laboratory data for accurate interpretation.

Use cfDNA testing to answer specific clinical questions that influence patient management.

cfDNA supports longitudinal monitoring of disease burden, particularly in oncology and transplantation.

Overutilization may occur without clear clinical indications; underutilization exists in transplant surveillance and transfusion medicine.

Patients undergoing prenatal testing, cancer patients, organ transplant recipients.

cfDNA testing can reduce the need for invasive procedures and provide insights into ongoing biological responses.

Standardize specimen collection and processing for cfDNA assays.
Implement robust bioinformatics pipelines for interpretation.
Educate clinicians and laboratory staff on appropriate test utilization and interpretation.